オプションチェーンは、Replimune Groupの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Replimune Groupの市場センチメントを評価します。.

Replimune Group (NASDAQ:REPL) 株価情報, オプションチェーン

REPLIMUNE GROUP INC

Replimune Group

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Replimune Group Inc

REPLENISH NUTRIENTS HLDG by REPLENISH NUTRIENTS HLDG CORP.

Replenish Nutrients Holding Corp

Repligen Corp

Reply SpA

News

Offerings

Haoxi Health Technology Files For Mixed Shelf Of Up To $80M

A gauge tracking the so-called &#8220;magnificent seven&#8221; — which includes Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>), Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>). Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) — surged 15% in May.
The rally coincided with an especially solid month for U.S. equities. The S&amp;P 500, tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), surged more than 6% for the month. That&#8217;s its strongest month since November 2023.
But beneath the surface <a href="https://www.benzinga.com/general/education/25/05/45675595/apple-eyes-worst-month-vs-sp-500-since-2018-but-history-says-buy-the-dip-now#:~:text=Apple%2520underperformed%2520S%2526P%2520500%2520by,expert%2520insights%2520for%252060%2525%2520off.">is Apple's rare underperformance.</a>
Six out of the magnificent seven tech giants logged monthly gains. The iPhone maker, however, lagged its peers and delivered its weakest relative performance against the S&amp;P 500 Index since 2018.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1024x535.png" alt="" class="wp-image-933762" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1536x803.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-2048x1070.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In contrast, Nvidia posted a staggering 24% monthly jump — its best performance since May 2024 — after delivering <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45668727/nvidia-stock-is-surging-thursday-whats-fueling-the-move">better-than-expected quarterly earnings.</a>
Despite facing export restrictions on its chips to China, Nvidia's revenue resilience confirmed that artificial <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45675006/nvidia-stock-has-significant-upside-as-ai-godfather-jensen-huang-delivers-another-robust-quarter">intelligence demand remains healthy.</a> Overall revenue reached $44.1 billion, up 69% from a year ago.
"Countries around the world are recognizing AI as essential infrastructure — just like electricity and the internet — and Nvidia stands at the center of this profound transformation," CEO Jensen Huang said.
While Wall Street paints a positive picture, Main Street tells a different story, as pessimism among U.S. consumers runs high.
The U.S. economy contracted by 0.2% <a href="https://www.benzinga.com/government/regulations/25/05/45669445/us-economy-contracts-by-02-in-q1-labor-market-shows-signs-of-cracks-as-jobless-claims-surge">in the first quarter</a>, a slight upward revision from the initial -0.3% estimate, yet a stark reversal from the 2.4% growth rate seen in late 2024. Inflation, as measured by the <a href="https://www.benzinga.com/cannabis/25/05/45693219/feds-favorite-inflation-gauge-slows-but-trumps-china-accusation-flips-market-mood">Personal Consumption Expenditures price index</a>, cooled to 2.1% in April — its lowest pace in six months — from 2.3% in March.
But the public doesn&#8217;t seem to trust the disinflation narrative.
According to the University of Michigan's May survey, Americans expect inflation to run at 6.6% over the next year, <a href="https://www.benzinga.com/markets/economic-data/25/05/45697983/consumer-sentiment-stuck-at-3-year-lows-as-inflation-fears-hit-44-year-high">the highest level since 1981</a>. That figure reflects the widest gap ever recorded between perceived and actual inflation. Meanwhile, overall sentiment remains near three-year lows.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1024x535.png" alt="" class="wp-image-933763" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1536x803.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-2048x1070.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In a notable development on the trade front, the U.S. Court of International Trade struck down significant portions of President Donald Trump's newly proposed tariff actions.
While the move sparked brief investor optimism, analysts caution the Trump administration retains various legal avenues to <a href="https://www.benzinga.com/government/regulations/25/05/45672421/tariffs-blocked-by-court-but-goldman-sachs-says-trump-could-reimpose-them-within-days">reintroduce similar trade barriers.</a>
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/05/45703175/netflix-stock-could-climb-another-25-thanks-to-second-half-content-bonanza-says-bank-of-america">Netflix Stock Could Climb Another 25% Thanks To Second-Half &#8216;Content Bonanza,&#8217; Says Bank Of America </a></li>
</ul>
Image: Shutterstock

Tech

AAPL

AMZN

GOOGL

MSFT

NVDA

TSLA

Magnificent Seven Drive Wall Street's Rally, Nvidia Notches Best Month In A Year: This Week In Markets

Meta Platforms Shareholders Reject Dual Class Capital Structure Proposal

General

Eversource Energy Enters Equity Distribution Agreement With Multiple Manager; To Issue And Sell Shares Up To $1.2B

On May 29, 2025, D-Wave Quantum Inc. (the "Company") received proceeds in the aggregate amount of approximately $80.5 million in connection with the exercise of approximately 7.0 million warrants to purchase shares of the Company's common stock with an exercise price of $11.50 per warrant. These warrants were assumed by the Company in conjunction with the August 5, 2022 merger with DPCM Capital, Inc.

QBTS

D-Wave Quantum Receives ~$80.5M from Exercise Of 7M Warrants At $11.50 Each, Originating From 2022 Merger With DPCM Capital

Modiv Industrial Files For Mixed Shelf Of Up to $250M

CMDB

Costamare Bulkers Files For Mixed Shelf Of Up To $200M

On May 27, 2025, Brendon Fischer, the Interim Chief Financial Officer of Sow Good Inc. (the "Company"), informed the Company of his decision to resign, effective June 6, 2025. Mr. Fischer will assist the Company to ensure the successful transition of his responsibilities prior to his departure. His resignation is not the result of any disagreement with the Company regarding its operations, accounting or other policies or practices.

Management

SOWG

Sow Good Announces Brendon Fischer To Resign As Interim CFO, Effective June 6, 2025

RVPH

Reviva Pharmaceuticals  Enters Into At Market Issuance Sales Agreement; To Offer Up To $50M In Common Stock

CACI

CACI International Awarded Nearly $638M In New Contracts Within Intelligence Community To Support National Security Efforts

Financing

Humana Enters Into $5B Unsecured Revolving Credit Agreement; Agreement Permits Up To $1B Of Incremental Commitments; New Agreement Replaces Existing $2.1B Credit Agreement

Color Star Technology Co Louis Luo Resigned From His Position As Ceo; Samantha Huang Appointed As Ceo

SIEB

Siebert Financial Files For Mixed Shelf Of Up To $100M

<ul>
<li>The Generation Essentials Group and Black Spade Acquisition II Co Expect to Close the Business Combination on June 3, 2025.</li>
<li>TGE's Class A Ordinary Shares and Warrants are Expected to Be Listed on the New York Stock Exchange and NYSE American under Ticker Symbols "TGE" and "TGEWS", Respectively, Shortly After the Closing of the Business Combination, on a Date to be Announced.</li>
</ul>
The Generation Essentials Group ("TGE") and Black Spade Acquisition II Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSII#NASDAQ">BSII</a>) ("Black Spade II") today announced that their previously announced business combination (the "Business Combination") was approved at an extraordinary general meeting of Black Spade II's shareholders on May 30, 2025.
Complete official results of the vote will be included in a current report on Form 8-K to be filed by Black Spade II with the U.S. Securities and Exchange Commission.
The Business Combination is expected to close on June 3, 2025. Upon such closing, TGE will remain as the combined company, and its Class A ordinary shares and warrants are expected to be listed on the New York Stock Exchange and NYSE American under the ticker symbols "TGE" and "TGEWS", respectively, shortly thereafter, on a date to be announced.

BSII

Generation Essentials Group And Black Spade Acquisition II Co Set To Close Business Combination On June 3, 2025; TGE Shares To Trade On NYSE Under Ticker Symbol "TGE" Following Closing

DIST

Distoken Acquisition Corp Enters Business Combination Agreement With Youlife Group

Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.25) by 376 percent. This is a 58.67 percent decrease over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $1.06 million which missed the analyst consensus estimate of $1.48 million by 28.61 percent. This is a 36.85 percent decrease over sales of $1.68 million the same period last year.

Earnings

Earnings Misses

PSTV

Plus Therapeutics Q1 EPS $(1.19) Misses $(0.25) Estimate, Sales $1.06M Miss $1.48M Estimate

TVRD

Tvardi Therapeutics Files Prospectus Relates To Resale By Selling Stockholders Of Up To 2.1M Shares Of Common Stock

CNFR

Conifer Holdings Receives $10M Contingent Payment

MSGM

Motorsport Games Files Prospectus Related To Resale From Time To Time Of Up To 2.3M Shares Of Class A Common Stock By Selling Stockholders

Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) has outperformed the market over the past 20 years by 10.62% on an annualized basis producing an average annual return of 18.9%. Currently, Copart has a market capitalization of $49.73 billion. 
Buying $1000 In CPRT: If an investor had bought $1000 of CPRT stock 20 years ago, it would be worth $31,802.32 today based on a price of $51.48 for CPRT at the time of writing.
<h3>Copart's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748636153_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CPRT

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Health Care

Press Releases

Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma

Markets

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Replimune Announces Inducement Grants Under Nasdaq  Listing Rule 5635(c)(4)

Sibylla Biotech Appoints Former Bayer CEO, Dieter Weinand, as Chairman of the Board of Directors

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Comments

Replimune Group

Replimune Group (REPL) オプション

Replimune Group (NASDAQ:REPL) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル